Murphy challenges Sebelius's statement about abortifacient drugs.
02/29/2012
https://congress.gov...
We are here today to discuss the administration's recent decision to delay a substantial portion of the healthcare law--the requirement that...
Thank you, Chairman Pitts, for holding this hearing to further the discussion about FDA's authority over drug compounding.
It is very hard to legislate cultural change into a large federal agency.
I commend him for his efforts, and look forward to continue working with my colleagues to reform drug compounding rules.